Suzanne Duijst

1.4k total citations
33 papers, 1.1k citations indexed

About

Suzanne Duijst is a scholar working on Surgery, Oncology and Epidemiology. According to data from OpenAlex, Suzanne Duijst has authored 33 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 17 papers in Oncology and 10 papers in Epidemiology. Recurrent topics in Suzanne Duijst's work include Drug Transport and Resistance Mechanisms (16 papers), Pediatric Hepatobiliary Diseases and Treatments (10 papers) and Virus-based gene therapy research (7 papers). Suzanne Duijst is often cited by papers focused on Drug Transport and Resistance Mechanisms (16 papers), Pediatric Hepatobiliary Diseases and Treatments (10 papers) and Virus-based gene therapy research (7 papers). Suzanne Duijst collaborates with scholars based in Netherlands, France and Brazil. Suzanne Duijst's co-authors include Ronald P.J. Oude Elferink, Dirk R. de Waart, Koen van de Wetering, Coen C. Paulusma, Ulrich Beuers, Sunny Mahakena, Piter J. Bosma, Daniela Sommer, András Váradi and Robert S. Jansen and has published in prestigious journals such as PLoS ONE, Hepatology and Scientific Reports.

In The Last Decade

Suzanne Duijst

30 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suzanne Duijst Netherlands 16 374 302 256 238 212 33 1.1k
Shigenori Yamamoto Japan 19 699 1.9× 102 0.3× 108 0.4× 166 0.7× 278 1.3× 94 1.3k
Li H. Gu United States 19 507 1.4× 184 0.6× 163 0.6× 189 0.8× 265 1.3× 33 1.4k
Hiroshi Kanamori Japan 20 555 1.5× 153 0.5× 138 0.5× 223 0.9× 266 1.3× 44 1.6k
Javier Pereda Spain 24 345 0.9× 75 0.2× 247 1.0× 299 1.3× 693 3.3× 40 1.6k
Yongtao Xiao China 21 490 1.3× 106 0.4× 220 0.9× 279 1.2× 419 2.0× 61 1.3k
Tadasu Tsujii Japan 20 541 1.4× 334 1.1× 225 0.9× 472 2.0× 233 1.1× 73 1.6k
Antonio Tugores Spain 18 550 1.5× 113 0.4× 191 0.7× 78 0.3× 92 0.4× 57 1.3k
Yasutake Yamamoto Japan 22 346 0.9× 285 0.9× 152 0.6× 293 1.2× 247 1.2× 59 1.3k
Wing‐Kin Syn United States 16 380 1.0× 151 0.5× 129 0.5× 649 2.7× 210 1.0× 30 1.3k
Yan He China 20 772 2.1× 108 0.4× 145 0.6× 142 0.6× 113 0.5× 118 1.5k

Countries citing papers authored by Suzanne Duijst

Since Specialization
Citations

This map shows the geographic impact of Suzanne Duijst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne Duijst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne Duijst more than expected).

Fields of papers citing papers by Suzanne Duijst

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzanne Duijst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne Duijst. The network helps show where Suzanne Duijst may publish in the future.

Co-authorship network of co-authors of Suzanne Duijst

This figure shows the co-authorship network connecting the top 25 collaborators of Suzanne Duijst. A scholar is included among the top collaborators of Suzanne Duijst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzanne Duijst. Suzanne Duijst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Porteiro, Begoña, Reinout L.P. Roscam Abbing, Dirk R. de Waart, et al.. (2024). Inhibition of hepatic bile salt uptake by Bulevirtide reduces atherosclerosis in Oatp1a1 Ldlr mice. Journal of Lipid Research. 65(8). 100594–100594.
2.
Shi, Xiaoxia, Giulia Bortolussi, Fanny Collaud, et al.. (2024). Repeated dosing of AAV-mediated liver gene therapy in juvenile rat and mouse models of Crigler-Najjar syndrome type I. Molecular Therapy — Methods & Clinical Development. 32(4). 101363–101363. 2 indexed citations
3.
Chang, Jung‐Chin, Simei Go, Eduardo Hideo Gilglioni, et al.. (2021). Soluble adenylyl cyclase regulates the cytosolic NADH/NAD+ redox state and the bioenergetic switch between glycolysis and oxidative phosphorylation. Biochimica et Biophysica Acta (BBA) - Bioenergetics. 1862(4). 148367–148367. 16 indexed citations
4.
Aronson, Sem J., Remco van Dijk, Giulia Bortolussi, et al.. (2020). A Quantitative In Vitro Potency Assay for Adeno-Associated Virus Vectors Encoding for the UGT1A1 Transgene. Molecular Therapy — Methods & Clinical Development. 18. 250–258. 14 indexed citations
5.
Shi, Xiaoxia, Sem J. Aronson, Lysbeth ten Bloemendaal, et al.. (2020). Efficacy of AAV8-hUGT1A1 with Rapamycin in neonatal, suckling, and juvenile rats to model treatment in pediatric CNs patients. Molecular Therapy — Methods & Clinical Development. 20. 287–297. 15 indexed citations
6.
Abbing, Reinout L.P. Roscam, Davor Slijepcevic, Joanne M. Donkers, et al.. (2019). Blocking Sodium‐Taurocholate Cotransporting Polypeptide Stimulates Biliary Cholesterol and Phospholipid Secretion in Mice. Hepatology. 71(1). 247–258. 15 indexed citations
7.
Aronson, Sem J., Xiaoxia Shi, Suzanne Duijst, et al.. (2019). Liver-directed gene therapy results in long-term correction of progressive familial intrahepatic cholestasis type 3 in mice. Journal of Hepatology. 71(1). 153–162. 37 indexed citations
8.
Gilglioni, Eduardo Hideo, Jung‐Chin Chang, Suzanne Duijst, et al.. (2018). Improved oxygenation dramatically alters metabolism and gene expression in cultured primary mouse hepatocytes. Hepatology Communications. 2(3). 299–312. 28 indexed citations
9.
Dijk, Remco van, Sem J. Aronson, Dirk R. de Waart, et al.. (2017). Biliverdin Reductase inhibitors did not improve severe unconjugated hyperbilirubinemia in vivo. Scientific Reports. 7(1). 1646–1646. 19 indexed citations
10.
Jonge, Hugo R. de, Jung‐Chin Chang, Kam S. Ho‐Mok, et al.. (2016). The phospholipid flippase ATP8B1 mediates apical localization of the cystic fibrosis transmembrane regulator. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1863(9). 2280–2288. 9 indexed citations
11.
Hakvoort, Theodorus B. M., Wim Kulik, Jacqueline L.M. Vermeulen, et al.. (2016). Pivotal role of glutamine synthetase in ammonia detoxification. Hepatology. 65(1). 281–293. 117 indexed citations
12.
Waart, Dirk R. de, et al.. (2015). ATP8B1 and ATP11C: Two Lipid Flippases Important for Hepatocyte Function. Digestive Diseases. 33(3). 314–318. 8 indexed citations
13.
Kunne, Cindy, Alexandra Acco, Suzanne Duijst, et al.. (2014). FXR-dependent reduction of hepatic steatosis in a bile salt deficient mouse model. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1842(5). 739–746. 31 indexed citations
14.
Kunne, Cindy, et al.. (2014). Hepatic cytochrome P450 deficiency in mouse models for intrahepatic cholestasis predispose to bile salt-induced cholestasis. Laboratory Investigation. 94(10). 1103–1113. 6 indexed citations
15.
Duijst, Suzanne, Johan K. Hiralall, Nicolas Legrand, et al.. (2014). Human fetal liver cells for regulated ex vivo erythropoietin gene therapy. Molecular Therapy — Methods & Clinical Development. 1. 14003–14003. 4 indexed citations
16.
Pichard, Virginie, Dominique Aubert, Lysbeth ten Bloemendaal, et al.. (2013). In the rat liver, Adenoviral gene transfer efficiency is comparable to AAV. Gene Therapy. 21(2). 168–174. 13 indexed citations
17.
Pañeda, Astrid, Lysbeth ten Bloemendaal, Suzanne Duijst, et al.. (2013). Adeno-Associated Viral Vector Serotype 5 Poorly Transduces Liver in Rat Models. PLoS ONE. 8(12). e82597–e82597. 13 indexed citations
18.
Waart, Dirk R. de, et al.. (2012). Overexpression of insulin like growth factor binding protein 5 reduces liver fibrosis in chronic cholangiopathy. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1822(6). 996–1003. 10 indexed citations
19.
Waart, Dirk R. de, Lysbeth ten Bloemendaal, Suzanne Duijst, et al.. (2012). Ezetimibe: A biomarker for efficacy of liver directed UGT1A1 gene therapy for inherited hyperbilirubinemia. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1822(8). 1223–1229. 6 indexed citations
20.
Waart, Dirk R. de, Koen van de Wetering, Cindy Kunne, et al.. (2011). Oral Availability of Cefadroxil Depends on ABCC3 and ABCC4. Drug Metabolism and Disposition. 40(3). 515–521. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shigenori Yamamoto Breakdown of academic impact, for papers by Li H. Gu Breakdown of academic impact, for papers by Hiroshi Kanamori Breakdown of academic impact, for papers by Javier Pereda Breakdown of academic impact, for papers by Yongtao Xiao Breakdown of academic impact, for papers by Tadasu Tsujii Breakdown of academic impact, for papers by Antonio Tugores Breakdown of academic impact, for papers by Yasutake Yamamoto Breakdown of academic impact, for papers by Wing‐Kin Syn Breakdown of academic impact, for papers by Yan He
Rankless by CCL
2026